Cigna and Express Scripts on Tuesday cleared their final state hurdle towards an expected merger closing on Thursday. On Tuesday, the companies received regulatory approval from New Jersey, the last state to weigh in after California and New York gave their permission, with conditions, last week. WHY THIS MATTERS The $ 67 billion merger is… Read More: Cigna, Express Scripts merger to close Thursday »
A Harvard addiction medicine specialist is getting calls from distraught parents around the country. A Stanford psychologist is getting calls from rattled school officials around the world. A federal agency has ordered a public hearing on the issue. Alarmed by the addictive nature of nicotine in e-cigarettes and its impact on the developing brain, public… Read More: Addicted to Vaped Nicotine, Teenagers Have No Clear Path to… »
FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation (CIC) Print this page Cambridge, Mass. – December 17, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) has announced that the U.S. Food and Drug Administration (FDA) has approved Motegrity™ (prucalopride), a once-daily, oral treatment option for adults with Chronic Idiopathic Constipation (CIC).1 Motegrity, a… Read More: FDA Approves Motegrity (prucalopride) for Adults with Chronic Idiopathic Constipation… »
Brief Published Dec. 19, 2018 Dive Brief: Consumers are getting “mixed messages” from the CMS Hospital Compare website and penalties levied by the Hospital Readmissions Reduction Program, undermining their ability to shop for quality care, according to a study in The American Journal of Managed Care. The researchers compared hospital grades posted on Hospital Compare for… Read More: Study finds 'mixed messages' in Medicare hospital ratings, penalty programs »